Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.
Understanding CAPA in Clinical Trials: A Practical Guide for CRAs
Mohamad-Ali Salloum, PharmD • February 9, 2026
Share
Corrective and Preventive Action—better known as CAPA —is one of the most important quality tools in clinical research. If you work as a Clinical Research Associate (CRA), CAPA will appear frequently in monitoring visits, audit findings, inspection reports, protocol deviations, and site issues.
Yet most CRAs are never formally trained on how to manage CAPA effectively.
This guide breaks CAPA down into simple, human language, provides real‑world examples, and explains how to approach it as a CRA.
1. What Is CAPA?
Corrective Action
A corrective action is something you do to fix a problem that has already happened.
Example — Outdated ICF used
A site used an outdated version of the informed consent form (ICF). Corrective actions include:
- retrain staff,
- re‑consent all active participants using the correct ICF,
- update site tools.
Preventive Action
A preventive action is something you do to stop the problem from happening again in the future.
Example — Preventing ICF version errors
- add a checklist to verify the current ICF version before each visit,
- store only the current version in a restricted folder.
Reference:
ICH GCP E6(R2) Section 5.20 — root cause & corrective action.
FDA Quality System Regulation (21 CFR 820.100) — CAPA system requirements.
2. Why Does CAPA Matter to CRAs?
As a CRA, you are responsible for:
- identifying issues at the site
- assessing if a CAPA is needed
- ensuring the CAPA is realistic and effective
- following up to ensure implementation
- documenting actions in monitoring reports
CAPA ensures:
Patient safety
Data integrity
Protocol compliance
Inspection readiness
3. The CAPA Process — Simplified
1. Problem Identification
What exactly happened?
2. Containment
Immediate actions to control the damage.
3. Root Cause Analysis
Why did it happen?
- 5 Whys
- Fishbone/Ishikawa diagram
- Process mapping
4. Corrective Actions
5. Preventive Actions
6. Effectiveness Check
Did it work?
4. CAPA Examples and Case Scenarios for CRAs
Scenario 1: Missing Temperature Logs
Issue: Temperature logs were missing for 3 days.
Root cause: Study nurse was on emergency leave; no backup.
Corrective actions:
- Check current temperature & confirm no excursion.
- Retrain staff.
Preventive actions:
- Assign backup staff.
- Add reminders/alarms.
- Weekly PI/coordinator cross-check.
CRA follow‑up:
- Logs updated
- Backup trained
- Docs complete
Scenario 2: Visit Window Errors
Issue: Visits outside window.
Root cause: Manual calculations → errors.
Corrective actions:
- Recalculate all visit windows.
- Retrain coordinator.
Preventive actions:
- Validated visit window calculator.
- Checks in tracking logs.
Scenario 3: Missing ICF Signatures
Issue: Signatures missing on ICF pages.
Root cause: Staff rushing.
Corrective actions:
- Re-consent subjects.
- Retrain staff.
Preventive actions:
- Signature checklist.
- “Pending CRA review” ICF folder.
5. CRA Tips to Manage CAPA Effectively
✔ Ask the right questions
- “Walk me through the process.”
- “Who is responsible? What if absent?”
✔ Ensure realistic CAPA
CAPAs must be measurable, assignable, time-bound.
✔ Document everything
✔ Follow up every visit
✔ Focus on prevention, not blame
Goal: Find cause → Fix cause → Prevent recurrence.
6. Mini Quiz — Test Your Knowledge!
1.
Which describes a corrective action?
2.
A preventive action for visit window errors:
3.
Before corrective action comes:
4.
Wrong ICF version — root cause focuses on:
5.
CRA’s role in CAPA:
List of Services
ABOUT THE AUTHOR
Mohamad-Ali Salloum, PharmD
Share
Recent articles:
Confidence isn’t about eliminating fear—it’s about acting despite it. Discover how courage, discomfort, and psychological growth build real confidence over time.
References: McMurray JJV, Packer M, Desai AS, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med . 2014;371(11):993–1004. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med . 2007;357:2109–2122. Kastelein JJP, Akdim F, Stroes ESG, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med . 2008;358:1431–1443. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med . 2008;358:2545–2559. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med . 1991;324:781–788. Packer M, Anker SD, Butler J, et al. Effect of empagliflozin on cardiovascular and renal outcomes. N Engl J Med . 2020;383:1413–1424. Ioannidis JPA. Surrogate endpoints in clinical trials: are we being misled? BMJ . 2013;346:f314.
References: Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci . 2015;16(7):403‑18. Frisaldi E, Shaibani A, Benedetti F, Pagnini F. Placebo and nocebo effects associated with pharmacological interventions: an umbrella review. BMJ Open . 2023;13:e077243. Colloca L, Finniss D. Nocebo effects, patient‑clinician communication, and therapeutic outcomes. JAMA . 2012;307(6):567‑8. Howard JP, Wood FA, Finegold JA, et al. Side effect patterns in a blinded, randomized trial of statin, placebo, and no treatment. N Engl J Med . 2021;385(23):2180‑9. Penson PE, Mancini GBJ, Toth PP, et al. Introducing the “drucebo” effect in statin therapy. J Cachexia Sarcopenia Muscle . 2018;9(6):1023‑33. Barnes K, Faasse K, Geers AL, et al. Can positive framing reduce nocebo side effects? Front Pharmacol . 2019;10:167. Caliskan EB, Bingel U, Kunkel A. Translating knowledge on placebo and nocebo effects into clinical practice. Pain Rep . 2024;9(2):e1142. von Wernsdorff M, Loef M, Tuschen‑Caffier B, Schmidt S. Effects of open‑label placebos in clinical trials: a systematic review and meta‑analysis. Sci Rep . 2021;11:3855.
References: Zaniletti I, Larson DR, Lewallen DG, Berry DJ, Maradit Kremers H. How to distinguish correlation from causation in orthopaedic research. J Arthroplasty. 2023;38(4):634–637. Rush J, Ajami M, Look KA, Margolis A. Statistics review part 10: causality and confounding. J Pharm Soc Wis. 2014;17(1):45–52. Koopmans E, Schiller C. Understanding causation in healthcare: an introduction to critical realism. Qual Health Res. 2022;32(8–9):1207–1214. Kahlert J, Gribsholt SB, Gammelager H, Dekkers OM, Luta G. Control of confounding in the analysis phase – an overview for clinicians. Clin Epidemiol. 2017;9:195–204. Shi AX, Zivich PN, Chu H. A comprehensive review and tutorial on confounding adjustment methods for estimating treatment effects using observational data. Appl Sci (Basel). 2024;14(9):3662. Gao Y, Xiang L, Yi H, Song J, Sun D, Xu B, et al. Confounder adjustment in observational studies investigating multiple risk factors: a methodological study. BMC Med. 2025;23:132. Ho FK, Brown J, Galwey NW. Regression adjustment for causal inference. BMJ Med. 2025;4:e000816. Correia LCL, Mascarenhas RF, Menezes FSC, Oliveira Junior JS, Vaccarino V, Ross JS, et al. Confounder selection in observational studies in high‑impact medical and epidemiological journals. JAMA Netw Open. 2025;8(7):e2524176.
Explore the difference between Sensitivity and Specificity
References: Zaniletti I, Larson DR, Lewallen DG, Berry DJ, Maradit Kremers H. How to Distinguish Correlation from Causation in Orthopaedic Research. J Arthroplasty. 2022;38(4):634‑637. [pmc.ncbi.nlm.nih.gov] Association of Health Care Journalists. Correlation vs. Causation. [healthjournalism.org] Rush J, Ajami M, Look K, Margolis A. Statistics Review Part 10: Causality and Confounding. J Pharm Soc Wis. [jpswi.org] Biostat Prime. Correlation vs Causation: Meaning, Differences & Examples. [biostatprime.com] Koopmans E, Schiller C. Understanding Causation in Healthcare: An Introduction to Critical Realism. Qual Health Res. 2022;32(8–9):1207–1214. [pmc.ncbi.nlm.nih.gov]
References: Very Big Brain. Somatic Memories: How Physical Sensations Trigger Past Memories and Emotions . 2023 Nov 26. [verybigbrain.com] Misattribution of arousal. Wikipedia . 2026. [en.wikipedia.org] Zimbardo P. The Misattribution of Arousal Study (Dutton & Aron) . 2026. [zimbardo.com] Higgins L. Why You Feel Anxious After Drinking Coffee . TIME. 2025 Nov 11. [time.com] Double KS. Metacognitive ability is associated with reduced emotion suppression . Scientific Reports. 2026 Jan 28. [nature.com] Merkebu J et al. What is metacognitive reflection? Front Educ. 2023 Apr 5. [researchgate.net] Meyers S et al. Cognitive Reappraisal is More Effective for Regulating Emotions than Moods . Affective Science. 2025 Jun 6. [link.springer.com]
Are they the same?
A Practical Guide for the Public.
Did you know that your emotions are just suggestions?